Who
Eric Bjerkholt
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Mirum Pharmaceuticals; Director, Metagenomi Therapeutics; Director, Cerus; Director, Surrozen; Director, CalciMedica; Chief Financial Officer, Chinook Therapeutics; Chief Financial Officer, Aimmune Therapeutics; Director, Corium International.
In numbers
- Trades disclosed
- 255
- Buys
- 27
- Sells
- 17
- Bought
- $1.1M
- Sold
- $8.3M
- Companies
- 10
- Companies where not an officer
- 6
- First trade
- 1 Mar 2006
- Last trade
- 14 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Sep 2026filed 15 Sep 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $978K9,943 at $98.37 | filing |
| 14 Sep 2026filed 15 Sep 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $978K9,943 at $98.37 | filing |
| 11 Sep 2026filed 15 Sep 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —18,333 | filing |
| 11 Sep 2026filed 15 Sep 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,333 at $0.00 | filing |
| 11 Sep 2026filed 15 Sep 2026 | MIRM Mirum Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,333 at $0.00 | filing |
| 11 Sep 2026filed 15 Sep 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —18,333 | filing |
| 11 Aug 2026filed 12 Aug 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $600K6,001 at $99.90 | filing |
| 11 Aug 2026filed 12 Aug 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $599K6,001 at $99.90 | filing |
| 6 Jul 2026filed 8 Jul 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $380K3,124 at $121.67 | filing |
| 6 Jul 2026filed 8 Jul 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $128K1,048 at $122.43 | filing |
| 6 Jul 2026filed 8 Jul 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $65K528 at $123.84 | filing |
| 6 Jul 2026filed 8 Jul 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $37K300 at $124.94 | filing |
| 6 Jul 2026filed 8 Jul 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $380K3,124 at $121.67 | filing |
| 6 Jul 2026filed 8 Jul 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $128K1,048 at $122.43 | filing |
| 6 Jul 2026filed 8 Jul 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $65K528 at $123.84 | filing |
| 6 Jul 2026filed 8 Jul 2026 | MIRM Mirum PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $37K300 at $124.94 | filing |
| 9 Jun 2026filed 11 Jun 2026 | MGX Metagenomi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,000 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | MGX Metagenomi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,000 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $53K20,454 at $2.60 | filing |
| 9 Jun 2026filed 11 Jun 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $53K20,454 at $2.60 | filing |
News
Critical Survey: Mirum Pharmaceuticals (NASDAQ:MIRM) versus United Therapeutics (NASDAQ:UTHR)MIRM · themarketsdaily.com · 25 Oct 2026TransMedics Group (NASDAQ:TMDX) and Cerus (NASDAQ:CERS) Head-To-Head ContrastCERS · themarketsdaily.com · 13 Oct 2026Mirum Pharmaceuticals Meets Primary Endpoint In Phase 3 LIVMARLI StudyMIRM · rttnews.com · 12 Oct 2026Mirum Pharmaceuticals Reports Positive Phase 3 LIVMARLI Results; Plans FDA Filing In 2027MIRM · rttnews.com · 12 Oct 2026
0 headlines in the last 90 days name Eric Bjerkholt; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.